These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 29742)

  • 1. Blockade of lergotrile or apomorphine induced turning behavior by haloperidol and clozapine.
    Nakamura S; Engel J; Goldstein M
    Commun Psychopharmacol; 1978; 2(3):185-90. PubMed ID: 29742
    [No Abstract]   [Full Text] [Related]  

  • 2. Two dopamine receptors: supportive evidence with the rat rotational model.
    Tye NC; Horsman L; Wright FC; Large BT; Pullar IA
    Eur J Pharmacol; 1977 Sep; 45(1):87-90. PubMed ID: 560970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of anticholinergics and clozapine on the activation of the striatal dopaminergic system in the rat by haloperidol. Pharmacological findings (author's transl)].
    Sayers AC; Bürki HR
    Arzneimittelforschung; 1976; 26(6):1092-3. PubMed ID: 989384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of apomorphine-, bromocriptine- and lergotrile-induced circling behaviour in rats by subsequent haloperidol administration.
    Heal DJ; Green AR; Buylaert WA
    Neuropharmacology; 1980 Jan; 19(1):133-7. PubMed ID: 6102352
    [No Abstract]   [Full Text] [Related]  

  • 5. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.
    Schwarcz R; Fuxe K; Agnati LF; Hökfelt T; Coyle JT
    Brain Res; 1979 Jul; 170(3):485-95. PubMed ID: 37986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effects of apomorphine, haloperidol and clozapine on the synthesis and utilization of brain GABA.
    Lindgren S
    J Neural Transm; 1987; 69(1-2):47-57. PubMed ID: 3585320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo actions of clozapine and haloperidol on the turnover rate of acetylcholine in rat striatum.
    Racagni G; Cheney DL; Trabucchi M; Costa E
    J Pharmacol Exp Ther; 1976 Feb; 196(2):323-32. PubMed ID: 943521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of cholinergic agonists on apomorphine-induced stereotyped behavior in the rat.
    Sahakian BJ; Growdon JH; Millington WR; Barr JK; Wurtman RJ
    Commun Psychopharmacol; 1978; 2(3):255-62. PubMed ID: 568059
    [No Abstract]   [Full Text] [Related]  

  • 10. Differentiation of the central dopaminergic stimulants apomorphine and lergotrile.
    Wade RL; Krewsun I; Quock RM
    Proc West Pharmacol Soc; 1979; 22():141-2. PubMed ID: 42079
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of amantadine HCl on haloperidol-induced striatal dopamine neuron hypersensitivity.
    Allen RM; Flemenbaum A
    Biol Psychiatry; 1979 Jun; 14(3):541-4. PubMed ID: 573144
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system.
    Humpel C; Knaus GA; Auer B; Knaus HG; Haring C; Theodorsson E; Saria A
    Synapse; 1990; 6(1):1-9. PubMed ID: 1697986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral correlates of dopaminergic supersensitivity.
    Iversen SD; Creese I
    Adv Neurol; 1975; 9():81-92. PubMed ID: 1170717
    [No Abstract]   [Full Text] [Related]  

  • 14. Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors.
    Gnegy M; Uzunov P; Costa E
    J Pharmacol Exp Ther; 1977 Sep; 202(3):558-64. PubMed ID: 19618
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats.
    Jenner P; Rupniak NM; Marsden CD
    Psychopharmacology Suppl; 1985; 2():174-81. PubMed ID: 3159009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that the different properties of haloperidol and clozapine are not explained by differences in anticholinergic potency.
    Ljungberg T; Ungerstedt U
    Psychopharmacology (Berl); 1979 Feb; 60(3):303-7. PubMed ID: 108708
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine.
    Smith RC; Davis JM
    Life Sci; 1976 Sep; 19(5):725-31. PubMed ID: 986527
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
    Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-trial conditioned rotation in rats.
    Silverman PB
    NIDA Res Monogr; 1989; 95():540-1. PubMed ID: 2577050
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
    Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.